Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 2
1979 1
1980 3
1982 1
1989 2
1992 1
1993 1
1995 3
1996 11
1997 24
1998 21
1999 25
2000 10
2001 14
2002 14
2003 25
2004 13
2005 16
2006 30
2007 16
2008 23
2009 31
2010 21
2011 20
2012 23
2013 23
2014 21
2015 19
2016 26
2017 22
2018 15
2019 10
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

449 results
Results by year
Filters applied: . Clear all
Page 1
Treatment Approaches to Moderate to Severe Psoriasis.
Gisondi P, Del Giglio M, Girolomoni G. Gisondi P, et al. Int J Mol Sci. 2017 Nov 16;18(11):2427. doi: 10.3390/ijms18112427. Int J Mol Sci. 2017. PMID: 29144382 Free PMC article. Review.
Emollients, moisturizers, and keratolytic agents in psoriasis.
Fluhr JW, Cavallotti C, Berardesca E. Fluhr JW, et al. Clin Dermatol. 2008 Jul-Aug;26(4):380-6. doi: 10.1016/j.clindermatol.2008.01.015. Clin Dermatol. 2008. PMID: 18691519 Review.
Pharmacokinetics of tazarotene and acitretin in psoriasis.
Heath MS, Sahni DR, Curry ZA, Feldman SR. Heath MS, et al. Expert Opin Drug Metab Toxicol. 2018 Sep;14(9):919-927. doi: 10.1080/17425255.2018.1515198. Epub 2018 Sep 3. Expert Opin Drug Metab Toxicol. 2018. PMID: 30134735 Review.
Japanese guidelines for the management and treatment of generalized pustular psoriasis: The new pathogenesis and treatment of GPP.
Fujita H, Terui T, Hayama K, Akiyama M, Ikeda S, Mabuchi T, Ozawa A, Kanekura T, Kurosawa M, Komine M, Nakajima K, Sano S, Nemoto O, Muto M, Imai Y, Yamanishi K, Aoyama Y, Iwatsuki K; Japanese Dermatological Association Guidelines Development Committee for the Guidelines for the Management and Treatment of Generalized Pustular Psoriasis. Fujita H, et al. J Dermatol. 2018 Nov;45(11):1235-1270. doi: 10.1111/1346-8138.14523. Epub 2018 Sep 19. J Dermatol. 2018. PMID: 30230572
Acitretin Use in Dermatology.
Guenther LC, Kunynetz R, Lynde CW, Sibbald RG, Toole J, Vender R, Zip C. Guenther LC, et al. J Cutan Med Surg. 2017 Nov/Dec;21(3_suppl):2S-12S. doi: 10.1177/1203475417733414. Epub 2017 Sep 27. J Cutan Med Surg. 2017. PMID: 28952335 Review.
Role of Skin pH in Psoriasis.
Bigliardi PL. Bigliardi PL. Curr Probl Dermatol. 2018;54:108-114. doi: 10.1159/000489524. Epub 2018 Aug 21. Curr Probl Dermatol. 2018. PMID: 30130779 Review.
European S3-Guidelines on the systemic treatment of psoriasis vulgaris--Update 2015--Short version--EDF in cooperation with EADV and IPC.
Nast A, Gisondi P, Ormerod AD, Saiag P, Smith C, Spuls PI, Arenberger P, Bachelez H, Barker J, Dauden E, de Jong EM, Feist E, Jacobs A, Jobling R, Kemény L, Maccarone M, Mrowietz U, Papp KA, Paul C, Reich K, Rosumeck S, Talme T, Thio HB, van de Kerkhof P, Werner RN, Yawalkar N. Nast A, et al. J Eur Acad Dermatol Venereol. 2015 Dec;29(12):2277-94. doi: 10.1111/jdv.13354. Epub 2015 Oct 19. J Eur Acad Dermatol Venereol. 2015. PMID: 26481193 No abstract available.
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1).
Leonardi CL, Kimball AB, Papp KA, Yeilding N, Guzzo C, Wang Y, Li S, Dooley LT, Gordon KB; PHOENIX 1 study investigators. Leonardi CL, et al. Lancet. 2008 May 17;371(9625):1665-74. doi: 10.1016/S0140-6736(08)60725-4. Lancet. 2008. PMID: 18486739 Clinical Trial.
449 results
Jump to page
Feedback